ZYPREXA RELPREVV (nda022173)- (EQ 210MG BASE/VIAL,EQ 300MG BASE/VIAL,EQ 405MG BASE/VIAL)

Generic Name	OLANZAPINE PAMOATE	Innovator	CHEPLAPHARM
Dosage	EQ 210MG BASE/VIAL,EQ 300MG BASE/VIAL,EQ 405MG BASE/VIAL
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2018-Sep-30	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2012-Dec-11
GAIN Expiry	None	Drug Complexity	No
Indication	ZYPREXA® RELPREVV™ is a long-acting atypical antipsychotic for intramuscular injection indicated for the treatment of schizophrenia.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 210MG BASE/VIAL	**	**	-	-	-
EQ 300MG BASE/VIAL	**	**	-	-	-
EQ 405MG BASE/VIAL	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of ZYPREXA RELPREVV